However, the reduction of -SMA expression by OCA demonstrated a blockade of the fibrosis development process.-SMA expression is a hallmark of activated hepatic stellate cells (HSCs), serving as a key biomarker for liver fibrosis progression
Based on these data, the IGF-1 drug itself does not cause oncology, but only has a contraindication to use if you already have cancer or its predisposition (high cancer markers)
As companion supplements, the evidence-backed ones (protein, fiber, electrolytes, key vitamins) genuinely help you tolerate the drug and keep muscle
FIGURE 4 Glucagon-like peptide-1 receptor agonist-related other neoplasms Supplementary Figure S6 and Figure 5 demonstrate that the lower limit of PRR for GLP-1RA-associated bile duct cancer was greater than 1 in the first three models but less than 1 in model 4 (PRR 1.42, 95% CI 0.962.10, p = 0.03) and model 5 (PRR 1.39, 95% CI 0.952.03, p = 0.09)